Canopy Growth (CGC) vs Kamada (KMDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kamada (KMDA) has outperformed Canopy Growth (CGC) over the past year, gaining 13.7% versus a loss of 44.7%. Over five years, KMDA leads with a +47.5% price change compared with -99.4% for CGC. Kamada is the larger company by market cap ($448.7 million vs $380.5 million), about 1.2 times the size.
Kamada pays a dividend yielding 3.22%, while Canopy Growth does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CGC | KMDA |
|---|---|---|
| Share price | $0.8468 | $7.78 |
| Market cap | $380.47M | $448.70M |
| 1-day change | -3.39% | -1.46% |
| YTD return | -25.72% | +10.13% |
| 1-year return | -44.65% | +13.67% |
| 5-year return | -99.37% | +47.53% |
| P/E ratio (TTM) | — | 20.46 |
| Forward P/E | — | 13.48 |
| EPS (TTM) | $-0.45 | $0.38 |
| Dividend yield | 0.00% | 3.22% |
| Annual dividend | $0.00 | $0.25 |
| 52-week high | $2.38 | $9.35 |
| 52-week low | $0.81 | $6.55 |
| Distance from 52-week high | -64.42% | -16.84% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +41.71% | +73.63% |
| Average volume | 2.77M | 118.61K |
| Shares outstanding | 423.04M | 57.71M |
| Employees | 1,128 | 462 |
| Sector | Healthcare | Health Care |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KMDA has outperformed CGC by 58.3 percentage points over the past year.
- Kamada offers a meaningfully higher dividend yield (3.22% vs 0.00%).
- The two companies sit in different sectors: Canopy Growth in Healthcare and Kamada in Health Care.
About Canopy Growth
CGC stock →Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,128 employees
About Kamada
KMDA stock →Kamada Ltd. manufactures and sells plasma-derived protein therapeutics.
Health Care · Biotechnology: Pharmaceutical Preparations · 462 employees
CGC vs KMDA FAQ
Which is bigger, Canopy Growth or Kamada?
Kamada (KMDA) is larger, with a market capitalization of $448.70M compared with $380.47M for Canopy Growth (CGC).
Which stock has performed better over the past year, CGC or KMDA?
KMDA returned +13.67% over the past 12 months, compared with -44.65% for CGC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Canopy Growth or Kamada?
Kamada pays a dividend yielding 3.22%, while Canopy Growth does not currently pay a regular dividend.
Are Canopy Growth and Kamada in the same industry?
No. Canopy Growth is in the Healthcare sector, while Kamada is in Health Care.